Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
19.33
+0.17 (0.89%)
Aug 12, 2025, 4:00 PM - Market closed
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $560.73 million as of August 12, 2025. Its market cap has decreased by -3.56% in one year.
Market Cap
560.73M
Enterprise Value
322.44M
1-Year Change
-3.56%
Ranking
Category
Stock Price
$19.33
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $560.73M, an increase of 355.69%. That is a compound annual growth rate of 28.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 561.02M | -24.84% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | 1.62B | 176.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |